Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 1 min ago
PreprintAll rights reservedbioRxiv

Sex-stratified adipose-liver circuits in human MASLD

  • M. Koning
  • I. M. Hu
  • A. Kovynev
  • R. Landgraaf
  • A. H. Alizadeh Bahmani
  • D. Baars
  • D. Vojnovic Milutinovic
  • N. Velickovic
  • R. Franken
  • Y. Acherman
  • N. M. Hanssen
  • H. Herrema
6 more authors
  • A. Krag
  • F. Backhed
  • J. J. G. Bergman
  • M. Nieuwdorp
  • K. H. M. Prange
  • A. S. Meijnikman1
  1. 1Amsterdam UMC, University of Amsterdam; Amsterdam UMC, Vrije Universiteit Amsterdam
Read full textPDFDOICite

Related

  1. Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
    Brandon J. Perumpail, Andrea Tou, Jennifer Panganiban
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
    Xinyue Pang, Nan Geng, Chenqi Lu +5
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis
    Syed Muhammad Hassan Bukhari, Ushna Shahid, Wahhaj Qayyum +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
    Michihiro Iwaki, Hiroshi Tobita, Yuya Seko +38
    eClinicalMedicinePeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref

Cite

BibTeXRIS
BibTeX
@misc{koning2026sexstratified,
  title = {{Sex-stratified adipose-liver circuits in human MASLD}},
  author = {M. Koning and I. M. Hu and A. Kovynev and R. Landgraaf and A. H. Alizadeh Bahmani and D. Baars and D. Vojnovic Milutinovic and N. Velickovic and R. Franken and Y. Acherman and N. M. Hanssen and H. Herrema and A. Krag and F. Backhed and J. J. G. Bergman and M. Nieuwdorp and K. H. M. Prange and A. S. Meijnikman},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.754015},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.754015v1},
}
RIS
TY  - UNPB
TI  - Sex-stratified adipose-liver circuits in human MASLD
AU  - M. Koning
AU  - I. M. Hu
AU  - A. Kovynev
AU  - R. Landgraaf
AU  - A. H. Alizadeh Bahmani
AU  - D. Baars
AU  - D. Vojnovic Milutinovic
AU  - N. Velickovic
AU  - R. Franken
AU  - Y. Acherman
AU  - N. M. Hanssen
AU  - H. Herrema
AU  - A. Krag
AU  - F. Backhed
AU  - J. J. G. Bergman
AU  - M. Nieuwdorp
AU  - K. H. M. Prange
AU  - A. S. Meijnikman
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.754015
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.754015v1
ER  -